전문 번역가, 번역 회사, 웹 페이지 및 자유롭게 사용할 수 있는 번역 저장소 등을 활용합니다.
randomizirano
randomised
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
vse randomizirano
all randomised
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
randomizirano zdravljenje
randomised treatment†
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
randomizirano kontrolirano preskušanje
randomized controlled trial
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
neodvisna onkološka ocena, vse randomizirano
independent oncology review,
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
oblika preskušanja: randomizirano, globalno, multicentrično, odprto
design: randomised, global multicentre, open-label
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
dvojno slepo, randomizirano, kontrolirano (botox) preizkušanje
repeated intramuscular injections at 6 and 13 week intervals up to a dose of 0.64 lethal dose unit (ldu)/ animal for xeomin and botox (approx.
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
eno veliko odprto, multicentrično, mednarodno randomizirano študijo tretje
one large, open-label, multicentre, international randomised phase iii study has been conducted in patients with newly diagnosed ph+ cml.
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
shire bo opravil randomizirano, primerjalno študijo pri bolnikih z et.
shire will conduct a randomised, comparative study in patients with et.
마지막 업데이트: 2012-04-11
사용 빈도: 2
품질:
randomizirano, odprto klinično preskušanje so opravili pri bolnikih z akutno simptomatsko pe.
a randomised, open-label, clinical trial was conducted in patients with acute symptomatic pe.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
randomizirano, dvojno slepo s placebom nadzorovano študijo so opravili pri 83 bolnikih s fap.
a randomized double-blind placebo controlled study was conducted in 83 patients with fap.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
pri preiskovancih z asimptomatskim hae so opravili randomizirano odprto farmakokinetično študijo zdravila cinryze s paralelnimi skupinami.
a randomised, parallel group, open-label pharmacokinetic study of cinryze was performed in subjects with non-symptomatic hae.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
zdravljenje pljučne embolije randomizirano, odprto klinično preskušanje so opravili pri bolnikih z akutno simptomatsko pe.
treatment of pulmonary embolism a randomised, open-label, clinical trial was conducted in patients with acute symptomatic pe.
마지막 업데이트: 2012-04-11
사용 빈도: 4
품질:
v randomizirano, s placebom nadzorovano preskušanje z dodatkom zdravila k obstoječemu zdravljenju so vključili 41 otrok s smei.
41 children with smei were included in a randomised, placebo-controlled, add-on trial.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
med študijo reset so bolniki opažanja v dnevnik zapisovali povprečno 57 dni med uvajalnim obdobjem in 59 dni med randomizirano fazo prekinitve zdravljenja.
during reset, patient diaries were recorded for an average of 57 days during the run-in phase and 59 days during the randomised-withdrawal phase.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
izvedeno je bilo eno samo randomizirano, multicentrično, nadzorovano preskušanje 2. faze belatacepta pri bolnikih z na novo presajenimi jetri.
a single, randomised, multi-center, controlled phase 2 trial of belatacept in de novo orthotopic liver transplant recipients was conducted.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
eno veliko odprto, multicentrično, mednarodno randomizirano študijo tretje faze so opravili pri bolnikih z na novo diagnosticirano ph+ kml.
one large, open-label, multicentre, international randomised phase iii study has been conducted in patients with newly diagnosed ph+ cml.
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질:
iz stopnje recidivov izpeljane spremenljivke / iz mrt - sekundarni opazovani dogodki izpeljane spremenljivke predmeti randomizirano dopolnjeno 1 leto dopolnjeni 2 leti
completing 1 years completing 2 years
마지막 업데이트: 2011-10-23
사용 빈도: 1
품질:
경고: 이 정렬은 잘못되었을 수 있습니다.
잘못된 경우 삭제해 주십시오.
bolniki so randomizirano prejemali injekcije zdravila zypadhera 405 mg vsake 4 tedne, 300 mg vsake 2 tedna, 210 mg vsake 2 tedna ali placebo vsake 2 tedna.
patients were randomized to receive injections of zypadhera 405 mg every 4 weeks, 300 mg every 2 weeks, 210 mg every 2 weeks, or placebo every 2 weeks.
마지막 업데이트: 2017-04-26
사용 빈도: 3
품질:
mah bo opravil multicentrično, randomizirano, odprto študijo faze 2a zdravila strensiq pri bolnikih s hipofosfatazijo (hpp) z naslednjima ciljema:
the mah should conduct a multicentre, randomized, open-label, phase 2a study of strensiq in patients with hypophosphatasia (hpp) to:
마지막 업데이트: 2017-04-26
사용 빈도: 1
품질: